Home

Headache

Read time: 3 min

Treat the patient, not a checklist - Dr Munir Khani from American University of Beirut Medical Center, Lebanon

That is the approach advocated by Dr Munir Khani, Associate Professor of Psychiatry at the American...

Read time: 3 min

Depression scars both morale and brain - Dr Marcelo Allevato from Rio de Janeiro, Brazil

Patients with depression suffer under a profound cultural as well as personal burden, says Dr...

Read time: 4 min

Congress highlights

Time for a three-way conversation: perspectives on depression

Talking, listening and a frank exchange of ideas. Online tools can support cross-communication...

Read time: 4 min

Congress highlights

What are the chances? - The search for biomarkers in bipolar disorders

Biomarkers that could help in earlier recognition of bipolar disorders (BD) or that could reveal...

Read time: 3 min

Congress highlights

New mechanisms underlying mood disorders

Disturbed glutamatergic function may be involved in the aetiology of depression. In the search for...

Read time: 1 min

Cognition and THINC-it® tool aligns with unmet need in depression

Read time: 1 min

The London School of Economics and Political Science: Workplace Depression

The consequence of depression on workplace productivity and global economics

Read time: 4 min

Congress highlights

Predictors of drug-related adverse events, and inflammatory mediators linked to depression

Threads from a clinical symposium on biomarkers may help identify people at risk of depression and...

Read time: 3 min

Congress highlights

The new and the old – lessons for management of bipolar disorder

Attempts to treat and manage bipolar disorder (BD) predate current BD definitions and many of the...

Read time: 4 min

Congress highlights

THINC-it® a game changer in depression-related cognition

Clinicians and patients can now benefit from a free digital screening tool for cognitive...

Read time: 4 min

Congress highlights

Rediscovering drug discovery in bipolar disorder

Historically, advances in the treatment of bipolar disorder (BD) have been, at best, slow and...

Read time: 3 min

Positive about the negative in schizophrenia

It’s not all doom and gloom about negative symptoms in schizophrenia. Indeed, much has been...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country